Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 – Regional Analysis – By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others)

Send Enquiry
Item ID: BMIRE00025314 Category: Tag:

$2,485 – $3,885

Description

The Asia Pacific infectious disease diagnostics market was valued at US$ 4,673.02 million in 2022 and is expected to reach US$ 8,165.77 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Rising Number of Product Approvals and Launches Drives Asia Pacific Infectious Disease Diagnostics Market

The small and big companies operating in the Asia Pacific infectious disease diagnostics market adopt various strategies such as regional expansion, new product launches, and technological advancements to increase their revenue. Infectious disease diagnostic products are safer and more effective than before with continued developments and technological advancements.

Following are a few recent developments in infectious disease diagnostics market:

In August 2023, Danaher Corp entered into a definitive agreement to acquire Abcam plc. Danaher would acquire all of the outstanding shares of Abcam for US$ 24.00 per share in cash, or a total enterprise valued of approximately US$ 5.7 billion including assumed indebtedness and net of acquired cash.

In May 2021, Torus Biosystems launched the US$ 25 million program to advance infectious disease diagnostics across healthcare facilities.

In December 2021, Roche launched the first infectious illness tests on the Cobas 5800 System, a new molecular laboratory instrument. Cobas HIV-1/HIV-2 Qualitative, Cobas HBV, cobas HCV, cobas HIV-1, and Cobas Omni Utility Channel kit are a few of these options.

In June 2021, Bio-Rad Laboratories launched PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, an accurate, sensitive, and cost-effective tool used to detect SARS-CoV-2 in a community’s wastewater.

In April 2020, CerTest Biotec and B.D. (Becton, Dickinson, and Company) announced that VIASURE SARS-CoV-2 Real-Time PCR Detection Kit adapted for the BD MAX System has been CE marked to the IVD Directive (98/79/C.E.).

The active participation of market participants in product innovation and development and an increase in product approvals are likely to boost the growth of the Asia Pacific infectious disease diagnostics market during 2022-2030.

Asia Pacific Infectious Disease Diagnostics Market Overview

According to a ChinaTown Online blog, in May 2022, ~1 in 7 people from the age range of 15-49 is infected with sexually transmitted diseases (STDs) in China. Chlamydia, gonorrhea, genital warts, and syphilis are the most common STDs. According to the WHO, overall ~370 million new cases of trichomoniasis, Neisseria gonorrhea (NG) infection, Chlamydia trachomatis (CT) infection, and syphilis, among others, were detected in China in 2020. ~35% of the new infections registered were CT, which is one of the world’s most commonly reported sexually transmitted infections (STIs). Further, the rising number of public-public and public-private partnerships to address challenges posed by infectious disease burden in the country is expected to boost the market growth in the coming years. For Instance, the Centers for Disease Control and Prevention (CDC, US) has been in collaboration with the Government of China, along with other partners based in the country, for ~30 years, addressing public health priorities that affect the US, China, and the world.

Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Infectious Disease Diagnostics Market Segmentation

The Asia Pacific infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country.

Based on product, the Asia Pacific infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022.

By technology, the Asia Pacific infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Asia Pacific infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022.

By testing type, the Asia Pacific infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Asia Pacific infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022.

Based on country, the Asia Pacific infectious disease diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific infectious disease diagnostics market in 2022.

Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the Asia Pacific infectious disease diagnostics market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 7.2% CAGR, the Asia Pacific Infectious Disease Diagnostics Market is Speculated to be Worth US$ 8,165.77 Million by 2030, Says the Research Team

According to the Research Team’ research, the Asia Pacific infectious disease diagnostics market was valued at US$ 4,673.02 million in 2022 and is expected to reach US$ 8,165.77 million by 2030, registering a CAGR of 7.2% from 2022 to 2030. Rising application of diagnostics in veterinary infectious disease and rising number of product approvals and launches are among the critical factors attributed to the Asia Pacific infectious disease diagnostics market expansion.

Veterinary infectious diseases negatively impact the health of domestic animals, livestock, and wildlife. As a result of intensive animal farming, there are conditions for the emergence and amplification of disease epidemics due to the genetic and physical proximity of the billions of animals, often in frail health, that are raised indoors every year. Moreover, animal farming contributes to the spread of infections from wild animals due to deforestation caused by the expansion of agricultural land use.

Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential to reduce economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally to detect animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, susceptible, and specific, with the ability to detect at a high volume.

Even though conventional virological methods are incredibly reliable, they are time-consuming and labor-intensive procedures. Lateral flow and enzyme-linked immunosorbent assay can be used for rapid detection. Multiplex bead immuno or Luminex assay is a fluorescent beads-based high-throughput quantitative technique used for the detection of multiple antibodies specific for different infectious diseases at the same time in a single reaction, leading to more rapid, economical, and accurate results compared with conventional ELISA. In addition, the protein chip based on surface plasmon resonance (SPR) appears to be a rapid valuable tool in the sero-diagnosis of infection or antibody titration. Recombinant antibodies can also be produced in heterologous systems by using rDNA technology and used for developing diagnostic tests.

Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10-35 kg that is carried at the field level and used for validating African swine fever virus, classical swine fever virus, avian influenza virus, and foot-and-mouth disease virus for research purposes.

Similarly, Boster offers Bosterbio qPCR kits to detect up to 48 individual or pooled samples. It is used for gene expression profiling, target DNA quantification, microbial detection, viral or bacterial pathogen load determination, and evaluation of primer pair performance for probe-based qPCR. Thus, diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals is fueling the diagnostics in veterinary diagnosis.

On the contrary, inadequate reimbursement scenario hampers the growth of Asia Pacific infectious disease diagnostics market.

Based on product, the Asia Pacific infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held 68.2% share of the Asia Pacific infectious disease diagnostics market in 2022, amassing US$ 3,185.08 million. It is projected to garner US$ 5,472.90 million by 2030 to expand at 7.0% CAGR during 2022-2030.

By technology, the Asia Pacific infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The molecular-based diagnostic techniques segment held 47.0% share of the Asia Pacific infectious disease diagnostics market in 2022, amassing US$ 2,197.00 million. It is projected to garner US$ 4,018.04 million by 2030 to expand at 7.8% CAGR during 2022-2030. The immunodiagnostics segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Asia Pacific infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held 81.6% share of the Asia Pacific infectious disease diagnostics market in 2022, amassing US$ 3,813.06 million. It is projected to garner US$ 6,510.60 million by 2030 to expand at 6.9% CAGR during 2022-2030.

By testing type, the Asia Pacific infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held 85.6% share of the Asia Pacific infectious disease diagnostics market in 2022, amassing US$ 3,998.32 million. It is projected to garner US$ 6,787.93 million by 2030 to expand at 6.8% CAGR during 2022-2030. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Asia Pacific infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held 43.4% share of the Asia Pacific infectious disease diagnostics market in 2022, amassing US$ 2,027.33 million. It is projected to garner US$ 3,627.82 million by 2030 to expand at 7.5% CAGR during 2022-2030.

Based on country, the Asia Pacific infectious disease diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 31.0% share of Asia Pacific infectious disease diagnostics market in 2022, amassing US$ 1,447.24 million. It is projected to garner US$ 2,372.15 million by 2030 to expand at 6.4% CAGR during 2022-2030.

Key players operating in the Asia Pacific infectious disease diagnostics market are Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories Inc, and DiaSorin SpA, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific infectious disease diagnostics market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Asia Pacific Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Infectious Disease Diagnostics Market – Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Rising Incidence of Infectious Diseases
4.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
4.2 Market Restraints
4.2.1 Inadequate Reimbursement Scenario
4.3 Market Opportunities
4.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
4.4 Future Trends
4.4.1 Rising Number of Product Approvals and Launches
4.5 Impact Analysis:
5. Infectious Disease Diagnostics Market – Asia Pacific Market Analysis
5.1 Asia Pacific Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
6.3 Kits & Reagents
6.3.1 Overview
6.3.2 Kits & Reagents: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Instruments
6.4.1 Overview
6.4.2 Instruments: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Software & Services
6.5.1 Overview
6.5.2 Software & Services: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
7.3 Biosensor-based
7.3.1 Overview
7.3.2 Biosensor-based: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Immunodiagnostics
7.4.1 Overview
7.4.2 Immunodiagnostics: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
7.5 Molecular-Based Diagnostic Techniques
7.5.1 Overview
7.5.2 Molecular-Based Diagnostic Techniques: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
7.6 Clinical Biology
7.6.1 Overview
7.6.2 Clinical Biology: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Application Type
8.1 Overview
8.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
8.3 Point-of-Care Testing
8.3.1 Overview
8.3.2 Point-of-Care Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Laboratory Testing
8.4.1 Overview
8.4.2 Laboratory Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Testing Type
9.1 Overview
9.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
9.3 Human Testing
9.3.1 Overview
9.3.2 Human Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
9.4 Veterinary Testing
9.4.1 Overview
9.4.2 Veterinary Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 Diagnostic Laboratories: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals and Clinics
10.4.1 Overview
10.4.2 Hospitals and Clinics: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Homecare Settings
10.6.1 Overview
10.6.2 Homecare Settings: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Infectious Disease Diagnostics Market – Country Analysis
11.1 Asia Pacific Infectious Disease Diagnostics Market – Country Analysis
11.1.1 Asia Pacific Asia Pacific Infectious Disease Diagnostics Market, by Country
11.1.1.1 China
11.1.1.1.1 Overview
11.1.1.1.2 China: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 China: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.1.4 China: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.1 China: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.2 China: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.1.5 China: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.1.6 China: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.6.1 China: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.7 China: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Japan
11.1.1.2.1 Overview
11.1.1.2.2 Japan: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.1 Japan: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.2 Japan: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.2.5 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.2.6 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.6.1 Japan: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.7 Japan: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 India
11.1.1.3.1 Overview
11.1.1.3.2 India: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 India: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 India: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.1 India: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.2 India: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.3.5 India: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.3.6 India: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.6.1 India: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.7 India: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 South Korea
11.1.1.4.1 Overview
11.1.1.4.2 South Korea: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.3 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.4.4 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.4.4.1 South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.4.4.2 South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.4.5 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.4.6 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.4.6.1 South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.4.7 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Australia
11.1.1.5.1 Overview
11.1.1.5.2 Australia: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.3 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.5.4 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.5.4.1 Australia: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.5.4.2 Australia: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.5.5 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.5.6 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.5.6.1 Australia: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.5.7 Australia: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Asia Pacific
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.3 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.6.5 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.6.6 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.6.6.1 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.6.7 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bruker Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cardinal Health Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Trinity Biotech Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AccuBioTech Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ACON Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 DiaSorin SpA
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Infectious Disease Diagnostics Market Segmentation
Table 2. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. China: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 9. China: Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. China: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. China: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. China: Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. Japan: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 20. Japan: Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 21. India: Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 22. India: Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 23. India: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 24. India: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 25. India: Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 26. India: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. India: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 28. India: Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 31. South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 32. South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 33. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 34. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 37. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 38. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 39. Australia: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 40. Australia: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 41. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 43. Australia: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 44. Australia: Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 46. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 47. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 48. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 49. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 50. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 52. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Organic Developments Done By Companies
Table 54. Inorganic Developments Done By Companies
Table 55. Glossary of Terms, Asia Pacific Infectious Disease Diagnostics Market
 

LIST OF FIGURES

Figure 1. Asia Pacific Infectious Disease Diagnostics Market Segmentation, By Country
Figure 2. Asia Pacific Infectious Disease Diagnostics Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 6. Kits & Reagents: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Software & Services: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
Figure 10. Biosensor-based: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunodiagnostics: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular-Based Diagnostic Techniques: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Biology: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
Figure 16. Point-of-Care Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Laboratory Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
Figure 19. Human Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Veterinary Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Diagnostic Laboratories: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospitals and Clinics: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Research Institutes: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Homecare Settings: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific Asia Pacific Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 28. Asia Pacific Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)
Figure 29. China: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Japan: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. India: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. South Korea: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Australia: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies – Asia Pacific Infectious Disease Diagnostics Market

1. Abbott Laboratories
2. AccuBioTech Co Ltd
3. ACON Laboratories Inc
4. Bio-Rad Laboratories Inc
5. Bruker Corp
6. Cardinal Health Inc
7. Danaher Corp
8. DiaSorin SpA
9. F. Hoffmann-La Roche Ltd
10. Trinity Biotech Plc

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030”